Dyno Therapeutics Information
Contact top employees from
Dyno Therapeutics
Summary
Dyno Therapeutics is a private company that has been in the industry for 7 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Co-Founder & CEO is occupied by Eric Kelsic. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of Dyno Therapeutics varies between 100K and 5.0M. Total funding of the company - $109M. To connect with Dyno Therapeutics employee register on SignalHire.
Organization Website | dynotx.com |
Social Links |   |
Industries | |
Headquarters Location | 343 Arsenal St, Watertown, Massachusetts, 02472 US |
Employees Size | 100-200 employees |
Specialties | AAV engineering, Machine learning, Synthetic biology, NGS, Data science, Gene Therapy, Genome Editing, AAV, Software Engineering, Protein Engineering |
DMA Code | Greater Boston |
Founded | 2018 |
Estimated Annual Revenue | $100K - 5.0M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2017 | Privately Held | 1 - 25 | < 1M | $6.7M | |
| 2018 | Privately Held | 25 - 100 | 2.5M | $113.8M | |
| 2018 | Privately Held | 1 - 25 | 2M | $95.5M | |
| 2017 | Privately Held | 25 - 100 | 2.5M | $845M | |
| 2009 | Privately Held | 25 - 100 | 4.8M | $7.5M | |
| 1998 | Public Company | 250 - 500 | 500.2M | $163.1M | |
| 2014 | Privately Held | 25 - 100 | 5M | $236.7M | |
| 1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
| 2013 | Public Company | 25 - 100 | 16.6M | $191M | |
| 2018 | Privately Held | 25 - 100 | < 1M | $5.3M | |
| 2011 | Privately Held | 100 - 250 | 82.5M | $203.6M | |
| 2014 | Privately Held | 200-500 | < 1M | $236.5M | |
| 1987 | Privately Held | 1.0K - 5.0K | 300M | $0 | |
| 2019 | - | 100-200 | - | $- | |
| 2002 | - | 1000-5000 | - | $- | |
| 2017 | - | 10-50 | - | $- |
Estimated Website Traffic
The chart shows a decline in traffic to the dynotx.com website. In September, traffic decreased to 3505, compared to 3561 in the previous month. The highest traffic in 2025 was recorded in July, reaching 3835 visits.
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
25Total number all of employee turnover
< 12joined positions
< 13joined positions
Current employees switched from
Ex-employees switched to
Number of employees by department
12Total number all of employee turnover
< 2Associate Director
< 2Senior Scientist
< 2Senior Machine Learning Engineer
< 1IT Manager
< 1Senior Research Associate
< 1Senior Director
< 1Sr Manager
< 1Associate Scientist II
< 1Head of Partnership Success
Length of Employment
Employee tenure at Dyno Therapeutics shows a diverse range of experience levels:
20% have been with the company for less than 1 year37% for 1–2 years24% for 3–4 years20% for 5–7 yearsEx-employees positions
In Company
Associate Director
2
Senior Scientist
2
Senior Machine Learning Engineer
2
IT Manager
1
Senior Research Associate
1
Senior Director
1
Sr Manager
1
Associate Scientist II
1
Head of Partnership Success
1
In New Company
1
Director
1
Scientist
1
Software Engineering Manager
1
Scientist II
1
Associate IT Manager
1
Machine Learning Engineer
1
Associate Scientist I
1
Senior Machine Learning Engineer
1
Head of Stewardship
1
Machine Learning Intern
Associate Director
2
Senior Scientist
2
Senior Machine Learning Engineer
2
IT Manager
1
Senior Research Associate
1
Senior Director
1
Sr Manager
1
Associate Scientist II
1
Head of Partnership Success
1
Director
1
Scientist
1
Software Engineering Manager
1
Scientist II
1
Associate IT Manager
1
Machine Learning Engineer
1
Associate Scientist I
1
Senior Machine Learning Engineer
1
Head of Stewardship
1
Machine Learning Intern
1
Contact top employees from
Dyno Therapeutics
Tyson Bertmaring
Head of Stewardship
Tyson Bertmaring
Head of Partnership Success
Stephen Malina
ML Eng Lead
Arpan Ghosh
Principal Scientist/ Sr. Manager
Daniel Bloodgood
Scientist II
Megan Cramer
Principal Scientist
Josh Wilde
Senior Scientist
Bobby Ryterski
Staff Software Engineer
Russell Katz
Project Manager
Josh Thomson
Associate IT Manager
Demarcus Briers
Scientist II
Mugdha Deshpande
Associate Director
Kimberly Insigne
Senior Scientist
Iris Cheong
Senior Director, Controller
Robyn Hamel
Senior Executive Assistant
Zachary Cargill
Associate Scientist
Christopher Reardon
Lead Process Design Engineer, AAV Production
Cameron Webster
Senior Machine Learning Engineer
Jesse Weller
Machine Learning Scientist
Roshana Krishnamurthy
Senior Research Associate
Aashutosh Vihani
Scientist II - Computational Biology
William Fassler
Research Associate II
Florence Qian
Research Associate II, CNS Medium Throughput
Aashutosh Vihani
Scientist II
Molly Griffin
Staff Accountant
Similar Companies
FAQ
Dyno Therapeutics operates in the Biotech industries. More details can be found on the official website: dynotx.com.
The headquarters of Dyno Therapeutics are located in Watertown, United States.
The current CEO of Dyno Therapeutics is Eric Kelsic
Dyno Therapeutics currently employs 100-200 people.
Dyno Therapeutics's revenue is approximately 2M.
Well-known competitors of Dyno Therapeutics include Biobot Analytics, Cedilla Therapeutics, Korro Bio, Inc. and ElevateBio.
